Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Ahlholm Frederick W Create: Alert

All | News | Filings
Date FiledTypeDescription
10/05/2023 4 Ahlholm Frederick W (SVP, CFO and Secretary) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns: Granted 42,850 options to buy @ $6.41, valued at $274.7k
05/02/2023 4 Ahlholm Frederick W (SVP, CFO and Secretary) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns: Granted 19,843 shares @ $0
Sold 3,580 shares @ $4.48, valued at $16k
12/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/18/2022 4 Ahlholm Frederick W (CFO) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns: Granted 180,000 options to buy @ $0.791, valued at $142.4k
12/16/2020 4 Ahlholm Frederick W (SVP, Chief Accounting Officer) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns: Sold 1,845 shares @ $2.64, valued at $4.9k
Exercised 5,000 restricted stock units @ $0
10/14/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/17/2020 4 Ahlholm Frederick W (SVP, Chief Accounting Officer) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns: Granted 137,784 options to buy @ $7.11, valued at $979.6k
05/27/2020 4 Ahlholm Frederick W (SVP, Chief Accounting Officer) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns: Sold 8,339 shares @ $15, valued at $125.1k
01/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/17/2019 4 Ahlholm Frederick W (SVP, Chief Accounting Officer) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns: Sold 1,557 shares @ $7.1, valued at $11.1k
Exercised 5,000 restricted stock units @ $0
12/18/2018 4 Ahlholm Frederick W (SVP, Chief Accounting Officer) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns: Sold 1,559 shares @ $7.46, valued at $11.6k
Exercised 5,000 restricted stock units @ $0
12/13/2018 4 Ahlholm Frederick W (SVP, Chief Accounting Officer) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns: Granted 120,000 options to buy @ $7.96, valued at $955.2k
12/15/2017 4 Ahlholm Frederick W (SVP, Chief Accounting Officer) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns: Sold 1,661 shares @ $5.8, valued at $9.6k
Granted 120,000 options to buy @ $6.1, valued at $732k
Exercised 5,000 restricted stock units @ $0
06/05/2017 4 Ahlholm Frederick W (SVP, Chief Accounting Officer) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns: Sold 11,250 shares @ $10, valued at $112.5k
Sold 10,381 shares @ $11, valued at $114.2k
Exercised 14,381 options to buy @ $5.19, valued at $74.6k
Exercised 7,250 options to buy @ $4.71, valued at $34.1k
12/29/2016 4 Ahlholm Frederick W (SVP, Chief Accounting Officer) has filed a Form 4 on Minerva Neurosciences, Inc.
12/16/2016 4 Ahlholm Frederick W (SVP, Chief Accounting Officer) has filed a Form 4 on Minerva Neurosciences, Inc.
12/08/2015 4 Ahlholm Frederick W (SVP, Chief Accounting Officer) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns: Granted 69,000 options to buy @ $0
04/16/2015 4 Ahlholm Frederick W (VP, Chief Accounting Officer) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns: Granted 57,524 options to buy @ $0
07/09/2014 4 Ahlholm Frederick W (Chief Accounting Officer) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns: Bought 10,000 shares @ $6, valued at $60k
Granted 93,541 options to buy @ $6, valued at $561.2k
02/03/2012 4 Form 4 - Statement of changes in beneficial ownership of securities
04/20/2011 4 Ahlholm Frederick W (Vice President Finance) has filed a Form 4 on AMARIN CORP PLC\UK
Txns: Sold 31,250 shares @ $15.883, valued at $496.3k
Exercised 31,250 options to buy @ $1.7, valued at $53.1k
04/06/2011 4 Ahlholm Frederick W (Vice President Finance) has filed a Form 4 on AMARIN CORP PLC\UK
Txns: Sold 31,250 shares @ $7.478, valued at $233.7k
Exercised 31,250 options to buy @ $1.7, valued at $53.1k
12/30/2010 3 Ahlholm Frederick W (Vice President Finance) has filed a Form 3 on AMARIN CORP PLC\UK

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy